Children with neuroblastomas may benefit from new drug cocktail

Children who develop neuroblastomas, a rare form of cancer which develops in nerve cells, may benefit from receiving certain anti-tumor drugs as well as chemotherapy, a new trial has found.

LabVantage named Global LIMS Company of the year by Frost & Sullivan

LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services, including purpose-built LIMS platforms enabling rapid deployment at reduced costs, today announced it has been

September 17, 2024

Moderna doubles down on rare diseases; FDA advisory committee votes on fall Covid campaign; Illumina CEO steps down; and more

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can

June 18, 2023

EHR ‘Nudge’ Cut Low-Value Surgery Rates in Older Breast Cancer Patients

A “nudge” intervention in an electronic health record (EHR) significantly reduced rates of low-value axillary surgery in older women with early-stage, clinically node-negative breast cancer,

July 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.